Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1998-6-30
|
pubmed:abstractText |
Platelet transfusion support is required during bone marrow aplasia following ablative chemotherapy and bone marrow progenitor cell transplantation (BMT). Amphotericin-B is frequently given to these patients, both therapeutically and prophylactically, and has been described to have a negative impact on the results of platelet transfusions. We conducted a prospective study of the effect of amphotericin-B on transfused platelet recovery and survival in 81 BMT or acute leukaemia patients. One hundred and ninety-five platelet transfusions administered to 81 consecutive patients were analysed. The platelets were transfused 2 h after the completion of amphotericin-B. Using this schedule resulted in no effect of amphotericin-B on platelet recovery or survival, although platelet increments were modestly depressed in patients receiving high- vs. low-dose amphotericin-B. We conclude that the timing of amphotericin-B infusion be evaluated in patients demonstrating poor platelet recovery and survival. Transfusing platelets at least 2 h after the completion of amphotericin-B decreases the detrimental effect of this antifungal agent on transfused platelet recovery and survival.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0958-7578
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
43-7
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:9569459-Amphotericin B,
pubmed-meshheading:9569459-Antifungal Agents,
pubmed-meshheading:9569459-Blood Platelets,
pubmed-meshheading:9569459-Bone Marrow Transplantation,
pubmed-meshheading:9569459-Cell Survival,
pubmed-meshheading:9569459-Drug Administration Schedule,
pubmed-meshheading:9569459-Graft Survival,
pubmed-meshheading:9569459-Humans,
pubmed-meshheading:9569459-Immunocompromised Host,
pubmed-meshheading:9569459-Mycoses,
pubmed-meshheading:9569459-Neoplasms,
pubmed-meshheading:9569459-Platelet Count,
pubmed-meshheading:9569459-Platelet Transfusion,
pubmed-meshheading:9569459-Retrospective Studies,
pubmed-meshheading:9569459-Thrombocytopenia,
pubmed-meshheading:9569459-Time Factors
|
pubmed:year |
1998
|
pubmed:articleTitle |
Transfusing platelets 2 h after the completion of amphotericin-B decreases its detrimental effect on transfused platelet recovery and survival.
|
pubmed:affiliation |
Cleveland Clinic Cancer Center, Cleveland Clinic Foundation, USA husseim@cesmtp.ccf.org
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|